Drug intelligence / Profile preview

Yi An Shi

Development stage: Unknown
Lead developer: Yidao Biotechnology
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Yi An Shi (怡安适) is a recombinant protein subunit vaccine developed by Shanghai Yidao Biotechnology and Jiangsu Zhonghui Yuantong Biotechnology for the prevention of herpes zoster (shingles) in adults aged 40 and older. The vaccine utilizes the Varicella-zoster virus (VZV) glycoprotein E (gE) as the primary antigen, which is expressed in Chinese Hamster Ovary (CHO) cells. It is designed to elicit a robust immune response, including both antigen-specific cellular and humoral immunity, to prevent the reactivation of latent VZV. Clinical development has included randomized, double-blind trials comparing commercial-scale and clinical-scale formulations to ensure consistency in safety and immunogenicity.

Brand names: Yi An Shi怡安适
Other names: Recombinant Zoster Vaccine (CHO cell)重组带状疱疹疫苗（CHO细胞）

Targets

gE (VZV glycoprotein E)

Beyond the preview

Go deeper on Yi An Shi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi An Shi.

Explore the full profile